Identification of familial hypercholesterolemia in patients with myocardial infarction: A Chinese cohort study

Vallejo-Vaz, 2015, Familial hypercholesterolaemia: A global call to arms, Atherosclerosis, 243, 257, 10.1016/j.atherosclerosis.2015.09.021 Goldberg, 2016, Knowing the Prevalence of Familial Hypercholesterolemia Matters, Circulation, 133, 1054, 10.1161/CIRCULATIONAHA.116.021673 De Backer, 2016, Lifestyle and risk factor management in people at high cardiovascular risk from Bulgaria, Croatia, Poland, Romania and the United Kingdom who participated in both the EUROASPIRE III and IV primary care surveys, Eur J Prev Cardiol, 23, 1618, 10.1177/2047487316645474 Raal, 2013, Elevated PCSK9 levels in untreated patients with heterozygous or homozygous familial hypercholesterolemia and the response to high-dose statin therapy, J Am Heart Assoc, 2, e000028, 10.1161/JAHA.112.000028 Nordestgaard, 2013, Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society, Eur Heart J, 34, 3478, 10.1093/eurheartj/eht273 Wald, 2015, Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction, Eur J Intern Med, 26, 127, 10.1016/j.ejim.2015.01.014 Nanchen, 2015, Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes, Eur Heart J, 36, 2438, 10.1093/eurheartj/ehv289 Gransbo, 2016, Risk factor exposure in individuals free from cardiovascular disease differs according to age at first myocardial infarction, Eur Heart J, 37, 1977, 10.1093/eurheartj/ehw026 Li, 2015, Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease, Ann Med, 47, 386, 10.3109/07853890.2015.1042908 Haralambos, 2015, Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales, Atherosclerosis, 240, 190, 10.1016/j.atherosclerosis.2015.03.003 Li, 2016, Effect of glycemic and lipid achievements on clinical outcomes type 2 diabetic, Chinese patients with stable coronary artery disease, J Diabetes Complications, 30, 115, 10.1016/j.jdiacomp.2015.09.016 Benn, 2012, Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication, J Clin Endocrinol Metab, 97, 3956, 10.1210/jc.2012-1563 Pang, 2015, Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit, J Clin Lipidol, 9, 703, 10.1016/j.jacl.2015.07.005 Sniderman, 2014, The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapies, J Am Coll Cardiol, 63, 1935, 10.1016/j.jacc.2014.01.060 Andres, 2011, Cardiovascular risk factors and lifestyle associated with premature myocardial infarction diagnosis, Rev Esp Cardiol, 64, 527 Guella, 2010, Effects of PCSK9 genetic variants on plasma LDL cholesterol levels and risk of premature myocardial infarction in the Italian population, J Lipid Res, 51, 3342, 10.1194/jlr.M010009 Goliasch, 2015, Premature myocardial infarction is strongly associated with increased levels of remnant cholesterol, J Clin Lipidol, 9, 801, 10.1016/j.jacl.2015.08.009 Wiesbauer, 2009, Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age), Eur Heart J, 30, 1073, 10.1093/eurheartj/ehp051 Rallidis, 2016, Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins, Atherosclerosis, 249, 17, 10.1016/j.atherosclerosis.2016.03.023 de Ferranti, 2016, Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES), Circulation, 133, 1067, 10.1161/CIRCULATIONAHA.115.018791 Nanchen, 2016, Prognosis of Patients with Familial Hypercholesterolemia After Acute Coronary Syndromes, Circulation, 134, 698, 10.1161/CIRCULATIONAHA.116.023007 Watts, 2014, Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation, Int J Cardiol, 171, 309, 10.1016/j.ijcard.2013.11.025 Hopkins, 2011, Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia, J Clin Lipidol, 5, S9, 10.1016/j.jacl.2011.03.452 Reiner, 2011, ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Eur Heart J, 32, 1769, 10.1093/eurheartj/ehr158 Rosenson, 1993, Myocardial injury: the acute phase response and lipoprotein metabolism, J Am Coll Cardiol, 22, 933, 10.1016/0735-1097(93)90213-K